XML 84 R74.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Stock-Based Compensation [Abstract]    
Schedule of Allocation of Non-Cash Stock-Based Compensation



 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Nine Months Ended



 

September 30,

 

September 30,



 

2017

 

2016

 

2017

 

2016



 

 

(unaudited)

 

 

(unaudited)

Cost of revenues

 

$

 

$

10 

 

$

18 

 

$

20 

Research and development

 

 

25 

 

 

108 

 

 

74 

 

 

141 

Selling, general and administrative

 

 

159 

 

 

280 

 

 

428 

 

 

497 

Total stock compensation expense

 

$

190 

 

$

398 

 

$

520 

 

$

658 





 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 



 

 

 

 



 

For the Year Ended

 

 



 

December 31,

 

 



 

2016

 

 

2015

 

 



 

 

 

 

 

Cost of revenues

 

$

25 

 

 

$

51 

 

 

Research and development

 

 

164 

 

 

 

118 

 

 

Selling, general and administrative

 

 

582 

 

 

 

437 

 

 

Total stock compensation expense

 

$

771 

 

 

$

606 

 

 



Schedule of Key Assumptions of Fair Value of Stock Options Granted



 

 

 

 

 

 



 

 

 

 

 

 



Nine Months Ended



September 30,



2017

 

2016



(unaudited)

Dividend yield

 

 %

 

 %

Risk free interest rates

 

0.71-1.65

 %

 

0.71-1.01

 %

Expected  volatility

 

45.3 to 59.4

 %

 

51.3 to 53.5

 %

Expected term (in years)

 

3.5 to 5.0

 

 

3.5 to 5.0    

 





 

 

 

 

 

 



 

 

 

 

 

 



 

For the Year Ended

 



 

December 31,

 



2016

 

2015

 



 

 

Dividend yield

 

 %

 

 %

Risk free interest rates

 

0.71-1.41

 %

 

0.841.56

 %

Expected  volatility

 

49.1 to 59.4

 %

 

51.2 to 63.9

 %

Expected term (in years)

 

3.5 to 5.0

 

 

3.5 to 5.0    

 



Schedule of Option Activity



 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Number of
Shares

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contractual
Life (In Years)

 

Aggregate
Intrinsic
Value

Outstanding at December 31, 2016

 

 

5,055,741 

 

$

3.00 

 

 

 

 

 

 

Options granted (1)

 

 

498,803 

 

 

2.25 

 

 

 

 

 

 

Options exercised

 

 

(46,073)

 

 

1.52 

 

 

 

 

 

 

Options forfeited

 

 

(50,001)

 

 

2.05 

 

 

 

 

 

 

Options cancelled or expired

 

 

(316,022)

 

 

2.83 

 

 

 

 

 

 

Outstanding at September 30, 2017

 

 

5,142,448 

 

$

2.96 

 

 

3.76 

 

$

986,578 

Vested or expected to vest at September 30, 2017

 

 

5,125,749 

 

$

2.96 

 

 

3.75 

 

$

950,550 

Exercisable at September 30, 2017

 

 

4,307,532 

 

$

3.03 

 

 

3.45 

 

$

969,126 



(1)

The expected to vest options are the result of applying the pre-vesting forfeiture rate assumptions to total unvested options.



 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 



 

Number of Shares

 

 

Weighted Average Exercise Price

 

Weighted Average Remaining Contractual Life (In Years)

 

Aggregate Intrinsic Value

Outstanding at December 31, 2015

 

 

4,218,139 

 

 

$

3.75 

 

 

 

 

 

 

Options granted

 

 

1,435,097 

 

 

 

2.45 

 

 

 

 

 

 

Options exercised

 

 

(21,912)

 

 

 

2.10 

 

 

 

 

 

 

Options forfeited

 

 

(52,781)

 

 

 

2.02 

 

 

 

 

 

 

Options cancelled or expired

 

 

(522,802)

 

 

 

7.44 

 

 

 

 

 

 

Outstanding at December 31, 2016

 

 

5,055,741 

 

 

$

3.00 

 

 

4.46 

 

$

875,225 

Vested or expected to vest at December 31, 2016 (1)

 

 

5,035,622 

 

 

$

3.00 

 

 

4.46 

 

$

875,030 

Exercisable at December 31, 2016

 

 

4,049,888 

 

 

$

3.08 

 

 

4.01 

 

$

865,475 

(1) The expected to vest options are the result of applying the pre-vesting forfeiture rate assumptions to total unvested options.